| pubmed-article:4557771 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4557771 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:4557771 | lifeskim:mentions | umls-concept:C1442161 | lld:lifeskim |
| pubmed-article:4557771 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:4557771 | lifeskim:mentions | umls-concept:C1514697 | lld:lifeskim |
| pubmed-article:4557771 | lifeskim:mentions | umls-concept:C0301869 | lld:lifeskim |
| pubmed-article:4557771 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:4557771 | pubmed:dateCreated | 1972-9-15 | lld:pubmed |
| pubmed-article:4557771 | pubmed:abstractText | Exposure of normal mouse spleen cells in vitro to highly (125)I-labeled dinitrophenyl (DNP)-protein carrier conjugates specifically inactivated cells able to mount an immune response to that hapten after in vivo challenge. The deletion was hapten specific and independent of the radioactive carrier to which the hapten was bound. DNP-binding cells were inactivated by radioactivity that was not part of the hapten, but was solely confined to the carrier moiety. The deletion of the anti-DNP response lasted 2-3 wk and could be specifically inhibited. | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4557771 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:4557771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4557771 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4557771 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:4557771 | pubmed:issn | 0022-1007 | lld:pubmed |
| pubmed-article:4557771 | pubmed:author | pubmed-author:BorelYY | lld:pubmed |
| pubmed-article:4557771 | pubmed:author | pubmed-author:GolanD TDT | lld:pubmed |
| pubmed-article:4557771 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4557771 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:4557771 | pubmed:volume | 136 | lld:pubmed |
| pubmed-article:4557771 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4557771 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4557771 | pubmed:pagination | 305-17 | lld:pubmed |
| pubmed-article:4557771 | pubmed:dateRevised | 2010-9-10 | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:meshHeading | pubmed-meshheading:4557771-... | lld:pubmed |
| pubmed-article:4557771 | pubmed:year | 1972 | lld:pubmed |
| pubmed-article:4557771 | pubmed:articleTitle | Deletion of hapten-binding cells by a highly radioactive 125-I conjugate. | lld:pubmed |
| pubmed-article:4557771 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:4557771 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4557771 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4557771 | lld:pubmed |
